TMAB Therapeutics
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
TMAB is on a mission to develop two first-in-class humanized antibodies targeting two newly discovered signalling pathways trigger a strong immune response to otherwise treatment resistant lung, ovarian and colorectal cancer.
Address
HoustonTexas
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}